ArticleCureus2024
Hybrid Aortic Surgery: Clinical Outcomes and Techniques in Complex Aortic Pathologies.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Morphometric Aortic Remodeling and Mid-Term Outcomes After TEVAR for Acute Stanford Type B Aortic Dissection: A Single-Center Retrospective Cohort Study.Journal of clinical medicine · 2026Article
- Ferroptosis-related proteins orchestrate aortic dissection: unveiling novel molecular signatures and therapeutic avenues.Scientific reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThis study aimed to evaluate the clinical outcomes of hybrid aortic surgery in patients with complex aortic pathologies, with a focus on technical success, postoperative morbidity, and mortality.
methodsA retrospective observational study was conducted on 24 patients who underwent hybrid aortic surgery between 2019 and 2024. Four surgical approaches were categorized on the basis of the pathological location: (1) median sternotomy with bypass from the ascending aorta to the branches of the aortic arch, followed by thoracic endovascular aortic repair (TEVAR); (2) cervical incision with left carotid-to-subclavian bypass, right carotid-to-left carotid bypass, or right carotid-to-left subclavian bypass and TEVAR; (3) median laparotomy with bypass from the iliac arteries to the superior mesenteric artery, renal arteries, and celiac trunk followed by endovascular aortic repair (EVAR); and (4) femoral incision with crossover bypass and EVAR. Data on demographics, preoperative diagnoses, surgical techniques, and postoperative outcomes were collected.
resultsNo significant differences in demographic characteristics or comorbidities were found between the surgical groups. However, a significant association was observed between the location of the aortic pathology and the chosen surgical approach (p=0.019). Patients who underwent the femoral incision approach had a shorter hospital stay than those who did not (p=0.075). Postoperative complications were generally low across all groups; however, infection rates were higher at specific anatomical sites, such as the femoral incision area (p=0.002). No significant differences between the groups were observed in hospital or early mortality rates.
conclusionHybrid aortic surgery is a safe and effective approach for treating complex aortic pathologies, particularly when traditional open or endovascular procedures are individually insufficient. Minimally invasive techniques, such as femoral incisions, offer advantages in reducing recovery time but may be associated with higher infection rates in isolated anatomical sites. However, these benefits are questioned, and further studies with larger populations are needed to validate these findings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.